AlphAIalphai — Financial news for AI agents
Stock TitanAPR 32 min read$INTT

Rich Rogoff promoted to lead InTest (NYSE: INTT) as new CEO

InTest Corporation announced that Richard N. Grant, Jr. has stepped down as President, CEO, and director, effective immediately, as per his 2020 offer letter, not due to any disagreement. Richard Rogoff, formerly Vice President of Corporate Development, has been appointed as the new President, CEO, and director, with a compensation package including a $375,000 annual base salary and performance-based equity. This internal succession aligns with the Board's vision to scale the business and improve operational efficiency.

Original reporting
Stock Titan
Published Apr 3, 2026, 12:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 3, 2026, 1:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Rich Rogoff promoted to lead InTest (NYSE: INTT) as new CEO — source image
Source · Stock Titan
Decision brief

The 30-second read

$INTTBullishMed
01

Why it matters

Leadership change is expected to reinforce strategic initiatives, possibly leading to operational improvements.

02

Market read

The leadership change is a positive internal development with limited immediate broader market impact.

03

What to watch

Potential for internal conflicts or strategic shifts not disclosed publicly; macroeconomic factors could influence stock movement.

Timing: Immediate impact expected within days to weeks.

Background

InTest Corporation is a manufacturer with interests in technology and manufacturing sectors, with recent focus on operational efficiency.

Company-level read

Ticker impact

$INTTBullishHigh confidence
Context

High relevance due to recent leadership change and positive sentiment.

Expected impact

Moderate upward movement expected in the short term (1-3 months).

Evidence & confidence

Leadership stability and strategic alignment are positive signals; the company's internal succession reduces uncertainty.

Market effects

Sector

Potential positive sentiment in manufacturing and technology sectors due to leadership stability.

Regional

Limited regional impact; primarily company-specific.

Global

Minimal global market relevance unless company reports significant operational changes.

Counterpoint

What could challenge this read

Leadership change may lead to short-term volatility; some investors might perceive internal succession as a sign of limited growth prospects.

Key entities

  • Person
    Richard Rogoff

    New CEO of InTest Corporation, formerly Vice President of Corporate Development.

  • Company
    InTest Corporation

    Manufacturer focusing on technology and manufacturing sectors.

Read at source← All news

Related articles

AUG 11
$INTTMedAI 8/10

InTest (INTT) Q2 2026 Earnings Call Transcript

InTest (INTT) reported Q2 2026 revenue of $35.3M, up 25.5% YoY, with semi orders $12.0M (+64% YoY) and backlog $45.4M (+19.8% YoY). Full-year guidance raised to $135M-$140M. Gross margin was 40.5% and adjusted EBITDA $2.2M. CFO cited a material weakness at Alfamation.

fool.com6 min
AUG 10
$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Strong Second Quarter 2026 Revenue of $35.3 Million EPS of $0.04 and Adjusted EPS (Non-GAAP) of $0.09 • Second quarter revenue up 25.5% year-over-year, driven lar

SEC EDGAR 8-K6 min
AUG 3
$INTTMed

Why is inTest stock climbing today?

inTest Corp (INTT) shares rose 1.7% in pre-open trading after Northland upgraded the stock to “outperform” from “market perform” and set a $15.00 price target. Northland cited inTest’s preliminary Q2 2026 revenue estimate of about $35M and raised full-year 2026 revenue guidance to $135M-$140M, while noting a planned 220 bps gross margin reduction.

investing.com3 min
JUL 31
$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Preliminary Second Quarter 2026 Results • Second Quarter Revenue Estimated to be Approximately $35 Million • Second Quarter Gross Margin Estimated to be Approxima

SEC EDGAR 8-K6 min
SEP 8
$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

yahoo.com3 min
SEP 8
$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

theyeshivaworld.com2 min